USPTO serial 79265470
PB PB LEINER
Reviewed by CopyMark Law Group
Reg. 6132463Status 739Renewal
- Filing date
- Status date
- Registration date
- Aug 25, 2020
- Examiner
- CARR, PATRICK C
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PB PB LEINER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bradley M. Stohry
Bradley M. Stohry Reichel Stohry Dean LLP6151 Central AveIndianapolis, IN 46220United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Protein in raw material form for industrial manufacturing purposes; protein in raw material form for scientific and medical purposes; proteins for industrial purposes; proteins for use in manufacture; proteins for use in the manufacture of food supplements; proteins for the food industry; proteins for use in the manufacture of cosmetics; collagen for industrial purposes; gelatin for industrial purposes; chemical preparations for stimulating cooking for industrial purposes, namely, chemical foaming agents, thickening agents, stabilizing agents, gelling agents, binding agents, emulsifying agents; protein as a raw material for the food industry; protein for use in the manufacture of foodstuffs; proteins for use in the manufacture of food products; protein as a raw material for manufacturing food for human consumption; proteins for use in the manufacture of beverages; proteins for use in the manufacture of food stuffs, namely, proteins which form gels as part of the manufacturing process of human food stuffs; proteins for use in the manufacture of food stuffs, namely, proteins for human foodstuffs which form emulsions as part of the manufacturing process; collagen used as a raw ingredient in the manufacture of cosmetics; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; proteins for use in the manufacture of capsules for pharmaceuticals; proteins for use in the manufacture of pharmaceuticals, namely, proteins for encapsulation and microencapsulation of pharmaceuticals; proteins for use in the manufacture of food for animal consumption; proteins for use in the manufacture of veterinary products; collagen for industrial purposes; collagen for use in the manufacture of pharmaceuticals; collagen for use in the manufacture of foodstuffs; collagen for use in the manufacture of beverages; collagen for use in the manufacture of food supplements; collagen for use in the manufacture of veterinary products; collagen for use in the manufacture of food for animal consumption; collagen for use in the manufacture of capsules for pharmaceuticals; collagen for use in the manufacture of pharmaceuticals, namely, collagen for encapsulation and microencapsulation of pharmaceuticals; non-nutritive mixture of protein in the nature of collagen for use as an ingredient in the manufacture of food, namely, for forming an edible, external layer on food products during the co-extrusion processing of foodstuffs; collagen peptides as a raw material for industrial purposes; collagen peptides for industrial purposes; collagen peptides for use in the manufacture of foodstuffs; collagen peptides for use in the manufacture of beverages; collagen peptides for use in the manufacture of food supplements; collagen peptides used as a raw ingredient in the manufacture of cosmetics; collagen peptides for use in the manufacture of veterinary products; collagen peptides for use in the manufacture of food for animal consumption; collagen peptides for use in the manufacture of capsules for pharmaceuticals; collagen peptides for use in the manufacture of pharmaceuticals, namely, collagen for encapsulation and microencapsulation of pharmaceuticals; collagen peptides for use in the manufacture of coatings for pharmaceutical preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 2, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Oct 2, 2026 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Sep 21, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 8, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Aug 25, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 10, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 17, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 16, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 2, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 2, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 2, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 2, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 2, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 25, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 25, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 13, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 9, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 5, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 20, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 20, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 20, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 5, 2020 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| May 1, 2020 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Mar 30, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 24, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 20, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 20, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 9, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 19, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 1, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 1, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 25, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 24, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 7, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 3, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 30, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 15, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |